Nightingale Research is one of Australia’s largest private, community-based cardiovascular clinical trial organisations. We specialise in Phase 2 and Phase 3 studies, evaluating medications and interventions not yet approved by the Therapeutic Goods Administration (TGA) or listed on the Pharmaceutical Benefits Scheme (PBS).

By participating in our studies, patients gain early access to emerging therapies - often years before they become publicly available, under the care of our experienced clinical team.

Our dedicated research nurses and nurse practitioners bring over 50 years of combined clinical trial experience. Every participant receives personalised care, close monitoring, and compassionate support throughout their journey.

Participants can expect:

• Early access to next-generation treatments
• Personalised, concierge-style care
• Expert oversight and compassionate support from start to finish

We’re proud to advance medical research while making the latest therapies available directly within our local communities.